Antiseptic Market Size Overview | US$ 6,614.6 Million ROI by Top 10 Players By 2027, Owing To increasing Number of Surgical Procedures
Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
According to Global Antiseptics Market Report, by Application (Pre-surgical and Injectable Care, Skin and Hygiene Care, Oral Care, and Nasal Care), by Product Type (Solutions, Swabs, Wipes and Sponges, and Others), by End User (Hospitals and Clinics, Ambulatory Surgical Centers, Nursing Homes, Homecare Settings, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), published by Coherent Market Insights, the global antiseptics market was valued at US$ 4,448.9 million in 2018 and is expected to exhibit a CAGR of 5.1% over the forecast period (2019-2027).
Antiseptics are antimicrobial substances that are applied to living tissue/skin to reduce the possibility of infection, sepsis, or putrefaction during or after a surgical procedure.
Increasing number of surgical procedures is expected to propel growth of the global antiseptics market over the forecast period. For instance, according to Australian Institute of Health and Welfare’s Hospitals at a glance 2017–18 report updated in August 2019, admissions for emergency surgery increased between 2016-2017 and 2017-2018 by 2.9% in public hospitals and by 5.1% in private hospitals in Australia.
To know the latest trends and insights related to the global antiseptic market press release, click the link below: https://www.coherentmarketinsights.com/press-release/antiseptic-market-to-surpass-us-66146-million-by-2027-2487
Moreover, increasing number of road accidents is also expected to aid in growth of the global antiseptic market. For instance, according to the Centers for Disease Control and Prevention (CDC), in July 2019, around 6 million car accidents occur annually in the U.S. Moreover, around 3 million people get seriously injured due to car accidents every year and around 2 million drivers experience permanent injuries each year in the U.S.
Among applications, the pre-surgical and injectable care segment is expected to account for a major revenue share by 2027, owing to increasing prevalence of surgical site infections in the U.S. For instance, according to the Centers for Disease Control and Prevention (CDC), around 157,500 cases of surgical site infections (SSI) were occurred in the U.S. in 2018.
The market in Asia Pacific is driven by increasing number of road accidents. For instance, according to the Ministry of Road Transport and Highways (MRTH), Government of India, in 2017, around 147,000 deaths and 470,000 injuries were recorded in India due to road accidents.
Apply Promo Code “STAYHOME” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/3032
Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in April 2019, Becton, Dickinson and Company received the U.S. Food and Drug Administration (FDA) approval for BD ChloraPrep skin preparation with sterile solution, the only fully sterile chlorhexidine gluconate (CHG) antiseptic skin preparation, for commercial use in the U.S.
- The global antiseptic market expected to exhibit a CAGR of 5.1% over the forecast period (2019–2027)
- Increasing number of road accidents to augment growth of the global antiseptic market
- Major players operating in the global antiseptic market include 3M, STERIS Plc., Cardinal Health, Inc., Johnson & Johnson, Metrex Research, LLC, Procter & Gamble, Reckitt Benckiser Group Plc., Colgate-Palmolive Company, Kimberly-Clark Corporation, and Becton Dickinson and Company.
Other Related Reports:
Opoponax Extract Resinoid Market, by Product Type (Opoponax Gum and Opoponax Oil), By Indication (Antiseptic, Anti-spasmodic, Antibacterial, and Others), By Distribution Channel (Online Pharmacy, Retail Pharmacy, and Drug Stores), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027
Mouthwash Market, by Product Type (Fluoride, Cosmetics, Antiseptics, and Total Care), By Flavor (Active Salt, Mint Fresh Tea, and Others), By Distribution Channel (Hypermarkets, Supermarkets, Online, and Others), and by Region (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2018-2026
Halitosis Treatment Market, by Type (Pathological and Non-pathological), by Treatment (Antacids, Antiseptics, Antiplaque, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Trends, and Forecast to 2026About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire